Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Root Financial Partners LLC

Root Financial Partners LLC decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 18.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,957 shares of the medical equipment provider's stock after selling 673 shares during the quarter. Root Financial Partners LLC's holdings in Intuitive Surgical were worth $1,465,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also bought and sold shares of the company. Castleark Management LLC boosted its stake in shares of Intuitive Surgical by 3.4% during the 4th quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after purchasing an additional 2,990 shares in the last quarter. Ewing Morris & Co. Investment Partners Ltd. purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $454,000. Whalerock Point Partners LLC bought a new stake in Intuitive Surgical in the fourth quarter worth $209,000. Tounjian Advisory Partners LLC bought a new position in Intuitive Surgical in the 1st quarter worth about $5,152,000. Finally, Brighton Jones LLC increased its position in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after acquiring an additional 731 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Activity

In other news, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the transaction, the executive vice president now owns 2,245 shares in the company, valued at approximately $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 188 shares of the company's stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $515.91, for a total transaction of $96,991.08. Following the completion of the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded up $5.61 on Monday, reaching $539.32. The company had a trading volume of 292,939 shares, compared to its average volume of 1,989,084. The firm has a market cap of $193.30 billion, a price-to-earnings ratio of 79.04, a P/E/G ratio of 5.66 and a beta of 1.67. The firm's 50-day moving average price is $532.08 and its two-hundred day moving average price is $536.70. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 earnings per share. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have commented on ISRG shares. Evercore ISI reduced their target price on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a report on Wednesday, April 23rd. Royal Bank Of Canada reduced their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Barclays lowered their price objective on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. Finally, BTIG Research set a $560.00 target price on Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $588.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.